Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 23,523 |
|
|||||
| News | - | ||||||
| Day High | 0.22 | Low High |
|||||
| Day Low | 0.2033 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| CNS Pharmaceuticals Inc | CNSP | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.00235 | -1.11% | 0.209 | 11:35:21 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.219 | 0.2033 | 0.22 | 0.21135 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 61 | 23,523 | US$ 0.2139229 | US$ 5,032 | - | 0.19 - 2.98 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:35:21 | 1,117 | US$ 0.209 | USD |
CNS Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.1M | 5.25M | - | 0 | -18.85M | -3.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CNS Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/27/2024 | 16:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/21/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/06/2024 | 09:28 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/06/2024 | 09:28 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/06/2024 | 09:27 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/06/2024 | 09:26 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 2/02/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/31/2024 | 15:27 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 1/23/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/22/2024 | 05:02 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 1/10/2024 | 16:26 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 12/21/2023 | 08:15 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNSP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.2099 | 0.22 | 0.195 | 0.2115371 | 81,391 | -0.0009 | -0.43% |
| 1 Month | 0.30 | 0.3176 | 0.19 | 0.2283309 | 183,671 | -0.091 | -30.33% |
| 3 Months | 0.3008 | 0.478 | 0.19 | 0.3088887 | 256,671 | -0.0918 | -30.52% |
| 6 Months | 2.05 | 2.75 | 0.19 | 0.5024766 | 270,360 | -1.84 | -89.80% |
| 1 Year | 1.59 | 2.98 | 0.19 | 1.36 | 328,173 | -1.38 | -86.86% |
| 3 Years | 60.00 | 80.40 | 0.19 | 11.12 | 681,027 | -59.79 | -99.65% |
| 5 Years | 123.30 | 170.697 | 0.19 | 32.19 | 643,772 | -123.09 | -99.83% |
CNS Pharmaceuticals Description
| CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. |
